Research
Search
Genes / Clones
Expression
Mutants / Tg
Antibodies
Anatomy / GO / Human Disease / Chemical
Publications
Data Mining
Downloads
Data Model
AllianceMine
BioMart
Genomics
BLAST
ZFIN
Ensembl
NCBI
UCSC
Genome Browsers
ZFIN
Ensembl
Vega
GRC
UCSC
NCBI
Resources
Zebrafish Genomics
Other Genome Databases
Resources
General
The Zebrafish Book
Protocol Wiki
Antibody Wiki
Anatomy Atlases
Resources for Students and Educators
Zebrafish Programs
ZF-Health
Husbandry Resources
More...
Resource Centers
Zebrafish International Resource Center (ZIRC)
China Zebrafish Resource Center (CZRC)
European Zebrafish Resource Center (EZRC)
Community
Announcements
News
Meetings
Jobs
Alliance Community Forum
Search
People
Labs
Companies
Societies
International Zebrafish Society (IZFS)
Zebrafish Disease Models Society (ZDMS)
Genetics Society of America (GSA)
Zebrafish Husbandry Association
Support
Nomenclature
Nomenclature Conventions
Line Designations
Wild-Type Lines
Submit a Proposed Gene Name
Submit a Proposed Mutant/Tg Line Name
Publications
Guidelines for Authors
Zebrashare
Citing ZFIN
Using ZFIN
Help & Tips
Glossary
Single Box Search Help
Submit Data
Terms of Use
About Us
About ZFIN
Contact Information
Statistics
Committees
Jobs at ZFIN
Sign In
Phenotype Figure Summary
Marker:
atcaya
Conditions:
Standard or Control
Publication
Data
Fish
Anatomy
Sun
et al.
, 2015
Fig. 6
WT + MO1-atcaya
, 
WT + MO2-atcaya
motor neuron axon decreased length, abnormal
spinal cord motor neuron axon guidance decreased process quality, abnormal
Fig. 7
WT + MO1-atcaya
, 
ns10Tg + MO2-atcaya
, 
ns10Tg + MO1-atcaya
, 
WT + MO2-atcaya
motor neuron neuronal cell body
chata
expression mislocalised, abnormal
myotome acetylcholine-gated channel complex
chrna1
expression increased distribution, abnormal
myotome acetylcholine-gated channel complex increased area, abnormal
myotome neuromuscular junction of skeletal muscle fiber area, abnormal
myotome regulation of synaptic transmission, cholinergic decreased process quality, abnormal
regulation of synaptic transmission, cholinergic decreased process quality, abnormal
thigmotaxis decreased occurrence, abnormal
Fig. S7
WT + MO1-atcaya
, 
WT + MO2-atcaya
locomotion involved in locomotory behavior decreased occurrence, abnormal
myotome malformed, abnormal
thigmotaxis decreased occurrence, abnormal
Your Input Welcome
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Name:
Institution:
Email address:
Please leave blank:
Subject:
Comments:
Send your comments
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.